BioSpace News Archive

Dyadic International, Inc. announced it signed an expanded licensing agreement for its C1-cell protein expression platform with South Africa’s Rubic One Health to develop, manufacture, commercialize and distribute affordable vaccines and biologics for human and animal health in underserved African countries.

Day One Biopharmaceuticals announced an upcoming poster presentation at the 19th European Association of Dermato-Oncology Congress being held from April 20-22, 2023 in Rome, Italy.

Phathom Pharmaceuticals, Inc. announced today that members of its management team will participate in the following upcoming investor conferences.

Akoya Biosciences, Inc., The Spatial Biology Company®, announced they are partnering with Enable Medicine to introduce a cloud platform capable of significantly accelerating the analysis of high plex spatial image datasets generated by Akoya’s PhenoCycler-Fusion system.

Kala Pharmaceuticals, Inc. (NASDAQ:KALA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Kala’s human mesenchymal stem cell secretome (MSC-S) therapy (KPI-012) for the treatment of persistent corneal epithelial defect (PCED), a rare and debilitating ocular condition.

VectivBio Holding AG today announced they will report financial results for the full year ended December 31, 2022 and provide a business update on Wednesday, April 19, 2023 at 8:00 a.m. ET.

Creative Medical Technology Holdings, Inc. today announced positive one-year follow-up data and significant efficacy using CELZ-001 to treat patients with Type 2 Diabetes without any serious adverse effects reported.

Beacon Biosignals today announced it has named biotechnology industry veteran Christine Vietz, Ph.D., as Chief Research and Development Officer.

INOVIO today announced that an abstract has been accepted for presentation for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

Freenome, a privately held biotech company, announced that the Institute for Population and Precision Health at the University of Chicago has joined as a study partner for its Vallania Study.